- Home
- AACG vs PMN Comparison
AACG vs PMN Comparison
Compare AACG & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- PMN
- Stock Information
- Founded
- AACG 1999
- PMN 2004
- Country
- AACG China
- PMN Canada
- Employees
- AACG N/A
- PMN N/A
- Industry
- AACG Other Consumer Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- AACG Real Estate
- PMN Health Care
- Exchange
- AACG Nasdaq
- PMN Nasdaq
- Market Cap
- AACG 31.9M
- PMN 33.7M
- IPO Year
- AACG N/A
- PMN N/A
- Fundamental
- Price
- AACG $0.92
- PMN $0.97
- Analyst Decision
- AACG
- PMN
- Analyst Count
- AACG 0
- PMN 0
- Target Price
- AACG N/A
- PMN N/A
- AVG Volume (30 Days)
- AACG 24.9K
- PMN 49.2K
- Earning Date
- AACG 11-07-2024
- PMN 11-14-2024
- Dividend Yield
- AACG N/A
- PMN N/A
- EPS Growth
- AACG N/A
- PMN N/A
- EPS
- AACG N/A
- PMN N/A
- Revenue
- AACG $35,747,843.00
- PMN N/A
- Revenue This Year
- AACG N/A
- PMN N/A
- Revenue Next Year
- AACG N/A
- PMN N/A
- P/E Ratio
- AACG N/A
- PMN N/A
- Revenue Growth
- AACG 15.80
- PMN N/A
- 52 Week Low
- AACG $0.50
- PMN $0.87
- 52 Week High
- AACG $1.65
- PMN $2.61
- Technical
- Relative Strength Index (RSI)
- AACG 52.00
- PMN 47.68
- Support Level
- AACG $0.92
- PMN $0.89
- Resistance Level
- AACG $1.04
- PMN $1.02
- Average True Range (ATR)
- AACG 0.06
- PMN 0.07
- MACD
- AACG 0.01
- PMN -0.01
- Stochastic Oscillator
- AACG 66.13
- PMN 24.04
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.